ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTD.

Greg Del Val et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.